Through its subsidiary Cronos Australia Pty, the Cronos Group was recently granted a medicinal cannabis manufacture license by the Australian Office of Drug Control. With the license, Cronos can move forward on manufacturing cannabinoid-based products in Australia, through all forms of extraction, refining, concentration and transformation of the cannabis plant. Cronos Australia is a joint-venture between Cronos Group and Australia's NewSouthern Capital, that serves as the company's hub for Australia, New Zealand, and Southeast Asia.